European CommissionEC Medical Devices Unit s enNew RegulationsRegulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices,amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealingCouncil Directives 90/385/EEC and 93/42/EECRegulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnosticmedical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EUGuidance documents to the new regulationsTitle2.1 Scope, field ofapplication,definitionMEDDEV 2.1/1 (18 kB) Definitions of “medical devices”, “accessory” and “manufacturer”April 1994MEDDEV 2.1/2 rev.2 (14 kB) Field of application of directive “active implantable medicaldevices”April 1994MEDDEV 2.1/2.1 (12 kB) Treatment of Computers Used to Program Implantable PulseGeneratorsFebruary 1998MEDDEV 2.1/3 rev.3 (183 kB) Borderline products, drug-delivery products and medicaldevices incorporating,as integral part, an ancillary medicinal substance or an ancillaryhuman blood derivativeDecember 2009MEDDEV 2.1/4 (21 kB) Interface with other directives – Medicaldevices/directive89/336/EEC relating to electromagnetic compatibility and directive89/686/EEC relating to personal protective equipmentMarch 1994For the relation between the MDD and directive 89/686/EEC concerning personalprotective equipment, please see the Commission services interpretative document of21 August 2009 (28 kB)MEDDEV 2.1/5 (10 kB) Medical devices with a measuring functionJune 1998MEDDEV 2.1/6 (514 kB) Qualification and Classification of stand alone softwareJuly 20162.2 EssentialrequirementsMEDDEV 2.2/1 rev.1 (16 kB) EMC requirementsFebruary 1998MEDDEV 2.2/3 rev.3 (17 kB) “Use by”-dateJune 1998MEDDEV 2.2/4 (38 kB) Conformity assessment of In Vitro Fertilisation (IVF) and AssistedReproduction Technologies (ART) productsJanuary 20122.4 Classification ofMDMEDDEV 2.4/1 rev.9 (759 kB) Classification of medical devicesJune 20102.5 ConformityassessmentprocedureGeneral rules

Quality assurance.Regulatory auditing of quality systems of medical device manufacturers(See document in the GHTF-Global Harmonization Task Force)MEDDEV 2.5/3 rev.2 (8 kB) Subcontracting quality systems relatedJune 1998MEDDEV 2.5/5 rev.3 (7 kB) Translation procedureFebruary 1998MEDDEV 2.5/6 rev.1 (9 kB) Homogenous batches (verification of manufacturers'products)February 1998Conformity assessment for particular groups of productsMEDDEV 2.5/7 rev.1 (92 kB) Conformity assessment of breast implantsJuly 1998MEDDEV 2.5/9 rev.1 (96 kB) Evaluation of medical devices incorporating productscontaining natural rubber latexFebruary 2004MEDDEV 2.5/10 (80 kB) Guideline for Authorised RepresentativesJanuary 20122.7Clinical investigation,clinical evaluationMEDDEV 2.7/1 rev.4 (631 kB) Clinical evaluation: Guide for manufacturers andnotified bodiesJune 2016Appendix 1: Clinical evaluation on coronary stents (100 kB)December 2008MEDDEV 2.7/2 rev. 2 (412 kB) Guidelines for Competent Authorities for making avalidation/assessment of a clinical investigation application under directives90/385/EEC and 93/42/ECSeptember 2015MEDDEV 2.7/3 rev. 3 (383 kB) Clinical investigations: serious adverse reporting underdirectives 90/385/EEC and 93/42/EC - SAE reporting form (27 kB)May 2015The new SAE reporting form will be taken in use 1 September 2016 at the latest.MEDDEV 2.7/4 (183 kB) Guidelines on Clinical investigations: a guide formanufacturers and notified bodiesDecember 20102.10 Notified bodiesThe documents on designation of notified bodies under the new Regulations are inthe section above (MDCG documents)MEDDEV 2.10/2 rev.1 (105 kB) Designation and monitoring of Notified Bodies withinthe framework of EC Directives on Medical devicesAnnex 1 (119 kB), Annex 2 (14 kB), Annex 3 (16 kB), Annex 4 (26 kB)April 2001MEDDEV 2.12/1 rev.8 (763 kB)Guidelines on a Medical Devices Vigilance SystemJanuary 20132.12Market surveillanceⅠ. MEDDEV 2.12/1 rev.8 – Latest Version FormsMEDDEV 2.12/1 rev. 7 MIR and FSCA are still validActive PDF formsHow to use FSCA and MIR forms (12 kB)Manufacturer Incident Report - MIR (971 kB)Field Safety Corrective Action - FSCA (1 MB)MIR and FSCA xml files

Please note: Some browser plugins are not compatible with PDF forms. If you haveproblems opening these forms, please save them to your computer and open themfrom there.Other forms and templatesField Safety Notice Template (27 kB)Trend Report (151 kB)Periodic Summary Report (192 kB)Ⅱ. Device Specific Vigilance GuidanceDSVG Template (22 kB)DSVG 00 (20 kB) Introduction to Device Specific Vigilance GuidanceDSVG 01 (24 kB) Cardiac Ablation Vigilance Reporting GuidanceDSVG 02 (26 kB) Coronary Stents Vigilance Reporting GuidanceMEDDEV 2.12/2 rev.2 (228 kB) Post Market Clinical Follow-up studiesJanuary 20122.13 TransitionalperiodMEDDEV 2.13 rev.1 Commission communication on the application of transitionalprovision of Directive 93/42/EEC relating to medical devices (OJ 98/C 242/05)August 1998As regards the transitional regime of Directive 2007/47/EC see the InterpretativeDocument of the Commission's services of 5 June 2009 (35 kB)2.14 IVDMEDDEV 2.14/1 rev.2 (76 kB) Borderline and Classification issues. A guide formanufacturers and notified bodiesJanuary 2012MEDDEV 2.14/2 rev.1 (64 kB) Research Use Only productsFebruary 2004MEDDEV 2.14/3 rev.1 (80 kB) Supply of Instructions For Use (IFU) and otherinformation for In-vitro Diagnostic (IVD)Medical DevicesJanuary 2007Form for the registration of manufacturers and devices In Vitro Diagnostic MedicalDeviceDirective, Article 10 (213 kB)January 2007MEDDEV 2.14/4 (114 kB) CE marking of blood based in vitro diagnostic medicaldevices for vCJD based on detection of abnormal PrPJanuary 20122.15Other guidancesMEDDEV 2.15 rev.3 (32 kB) Committees/Working Groups contributing to theimplementation of the Medical Device DirectivesDecember 2008European Competent Authorities for Medical Devices and IVDR Transitional FAQs w-mdr-ivdrtransitional-faqs/Medical Devices Regulation/In-vitro Diagnostics Regulation (MDR/IVDR) mdr-ivdr-roadmap/Joint Action on Market Surveillance of Medical Devices (JAMS) rket-surveillance-of-medical-devices-jams/

Notified BodiesList of EU Notified ando/index.cfm?fuseaction /Designation of notified bodies under the new Regulations on medical devicesNotified BODIESDesignation of notified bodies under the new Regulations on medical devices1. Best practice guidance on designation and notification of conformity assessmentbodies (NBOG BPG 2017-1)2. Best practice guidance on the information required for conformity assessmentbodies' personnel involved in conformity assessment activities (NBOG BPG 2017-2)3. Application form to be submitted by a conformity assessment body when applyingfor designation as notified body under the medical devices Regulation (MDR) (NBOG F2017-1)4. Application form to be submitted by a conformity assessment body when applyingfor designation as notified body under the in vitro diagnostic devices Regulation (IVDR)(NBOG F 2017-2)5. Applied-for scope of designation and notification of a conformity assessment body –Regulation (EU) 2017/745 (MDR) (NBOG F 2017-3)6. Applied-for scope of designation and notification of a conformity assessment body –Regulation (EU) 2017/746 (IVDR) (NBOG F 2017-4)7. Preliminary assessment review template (MDR) (NBOG F 2017-5)8. Preliminary assessment review template (IVDR) (NBOG F 2017-6)9. Review of qualification for the authorisation of personnel (MDR) (NBOG F 2017-7)10. Review of qualification for the authorisation of personnel (IVDR) (NBOG F 2017-8)MHRA Guidance to Notified for-medical-devicesNomenclature and UDIPublication of first UDI guidance and requirements for medical device nomenclature: March vices/guidance enReferenceMDCG 2018-1MDCG 2018-2TitlePublication dateDraft guidance on basic UDI-DI and changes to UDI-DI March 2018Future EU medical device nomenclature – Description ofrequirementsSafetyAdverse event reporting from clinical investigations /guidance en

Mandate to SCHEER to produce guidelines On the benefit-risk assessment of the presence ofphthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic toreproduction (CMR) or have endocrine-disrupting /files/scientific committees/scheer/docs/scheer q 009.pdfOther resources and newsValue and Use of Patient Reported Outcomes in in Assessing Effects of Medical CDRHVisionandMission/UCM588576.pdfSoftware als Medizinprodukt es/1472724?cce em5e0cbb4d.%3Auyu72CakZNu7uDIDUTPbAP&link position digest&newsletter id 34464&toolbar true&xng share origin emailA New Era for Medical Devices: Current Regulatory -2018/a-new-era-for-medicaldevices/? ga 13672Resource library for medical device professionals (EMERGO) Medical devices Resources white papers es/resources/whitepapers/